Mapping epigenomic intratumoral heterogeneity in glioblastoma

Mapping glioblastoma in three dimensions (3D) reveals marked epigenomic intratumoral heterogeneity (ITH), researchers have reported.

Treatment failure in glioblastoma is often attributed to ITH as it facilitates the selection of resistant clones, according to Dr Radhika Mathur of the University of California San Francisco, USA. However, the extent of epigenomic ITH has not been established.

Therefore, Dr Mathur and colleagues developed a novel topographical approach to characterizing epigenomic ITH in 3D. They defined the tumor volume using preoperative MRI scans, and then acquired multiple samples intraoperatively.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.